
Regeneration Biomedical’s Cell Therapy Reduces Tau, Boosts Cognition in Alzheimer’s Cases
Patients in an ongoing Phase I clinical trial of a new stem cell therapy for Alzheimer’s disease (AD) are showing a reduction in proteins linked to disease progression and improvements in cognitive scoring. This is according to preliminary data from …